- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare DSP Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 4.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.93 | 1.94 |
NAV | ₹38.00 | ₹37.57 |
Fund Started | 12 Nov 2018 | 25 Jun 2018 |
Fund Size | ₹3018.76 Cr | ₹4914.64 Cr |
Exit Load | Exit load of 0.50% if redeemed within 1 month. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
4.0
4.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.93
1.94
NAV
₹38.00
₹37.57
Fund Started
12 Nov 2018
25 Jun 2018
Fund Size
₹3018.76 Cr
₹4914.64 Cr
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 18.72% | 24.40% |
3 Year | 20.16% | 23.98% |
5 Year | 24.82% | 25.65% |
1 Year
18.72%
24.40%
3 Year
20.16%
23.98%
5 Year
24.82%
25.65%
Holding Analysis
Equity | 98.63% | 98.28% |
Cash | 1.37% | 1.72% |
Equity
98.63%
98.28%
Cash
1.37%
1.72%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.78% |
Suven Pharmaceuticals Ltd. | 9.49% |
Cipla Ltd. | 8.55% |
Ipca Laboratories Ltd. | 7.98% |
Globus Medical Inc | 5.58% |
Gland Pharma Ltd. | 4.86% |
Laurus Labs Ltd. | 4.51% |
Alembic Pharmaceuticals Ltd. | 4.38% |
Apollo Hospitals Enterprise Ltd. | 4.27% |
Sai Life Sciences Ltd. | 4.03% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.50% |
Dr. Reddy's Laboratories Ltd. | 8.95% |
Cipla Ltd. | 8.85% |
Divi's Laboratories Ltd. | 6.71% |
Aurobindo Pharma Ltd. | 5.30% |
Lupin Ltd. | 4.73% |
Alkem Laboratories Ltd. | 4.42% |
Mankind Pharma Ltd. | 3.50% |
Gland Pharma Ltd. | 3.39% |
Zydus Lifesciences Ltd. | 3.10% |
Fund Manager
Name | Jay Kothari | Dharmesh Kakkad |
Start Date | 16 Mar 2018 | 23 Feb 2021 |
Name
Jay Kothari
Dharmesh Kakkad
Start Date
16 Mar 2018
23 Feb 2021
About Fund
Description | The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 12 Nov 2018 | 25 Jun 2018 |
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
12 Nov 2018
25 Jun 2018